Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 14, 2019; 25(38): 5814-5825
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5814
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5814
Variable | Number | Low expression (n = 67) | High expression (n = 83) | P value | |
Age (yr) | |||||
< 60 | 63 | 25 | 38 | 0.299 | |
≥ 60 | 87 | 42 | 45 | ||
Gender | |||||
Male | 69 | 30 | 39 | 0.789 | |
Female | 81 | 37 | 44 | ||
Tumor differentiation | |||||
Well/moderate | 80 | 33 | 47 | 0.372 | |
Poor | 70 | 34 | 36 | ||
T stage | |||||
T1-T2 | 81 | 45 | 36 | 0.003 | |
T3-T4 | 69 | 22 | 47 | ||
N stage | |||||
N0 | 39 | 16 | 23 | 0.598 | |
N1-N3 | 111 | 51 | 60 | ||
TNM stage | |||||
I-II | 109 | 49 | 60 | 0.909 | |
III | 41 | 18 | 23 | ||
Chemotherapy outcome | |||||
CR/PR | 67 | 38 | 29 | 0.019 | |
SD/PD | 83 | 30 | 53 |
- Citation: Zhang LH, Wang Y, Fan QQ, Liu YK, Li LH, Qi XW, Mao Y, Hua D. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer. World J Gastroenterol 2019; 25(38): 5814-5825
- URL: https://www.wjgnet.com/1007-9327/full/v25/i38/5814.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i38.5814